Literature DB >> 7592687

Serpin-protease complexes are trapped as stable acyl-enzyme intermediates.

D A Lawrence1, D Ginsburg, D E Day, M B Berkenpas, I M Verhamme, J O Kvassman, J D Shore.   

Abstract

The serine protease inhibitors of the serpin family are an unusual group of proteins thought to have metastable native structures. Functionally, they are unique among polypeptide protease inhibitors, although their precise mechanism of action remains controversial. Conflicting results from previous studies have suggested that the stable serpin-protease complex is trapped in either a tight Michaelis-like structure, a tetrahedral intermediate, or an acyl-enzyme. In this report we show that, upon association with a target protease, the serpin reactive-center loop (RCL) is cleaved resulting in formation of an acyl-enzyme intermediate. This cleavage is coupled to rapid movement of the RCL into the body of the protein bringing the inhibitor closer to its lowest free energy state. From these data we suggest a model for serpin action in which the drive toward the lowest free energy state results in trapping of the protease-inhibitor complex as an acyl-enzyme intermediate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592687     DOI: 10.1074/jbc.270.43.25309

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.

Authors:  E Stratikos; P G Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Regulation of protein function by native metastability.

Authors:  C Lee; S H Park; M Y Lee; M H Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.

Authors:  S P Bottomley; I D Lawrenson; D Tew; W Dai; J C Whisstock; R N Pike
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

4.  Cavities of alpha(1)-antitrypsin that play structural and functional roles.

Authors:  C Lee; J S Maeng; J P Kocher; B Lee; M H Yu
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

5.  Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environment.

Authors:  Marija Backovic; Efstratios Stratikos; Daniel A Lawrence; Peter G W Gettins
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

6.  Conformational change in elastase following complexation with alpha1-proteinase inhibitor: a CD investigation.

Authors:  Jean-Alain Bousquet; Jérôme Duranton; Yves Mély; Joseph G Bieth
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

7.  Specificity and reactive loop length requirements for crmA inhibition of serine proteases.

Authors:  Lisa D Tesch; Manikanahally P Raghavendra; Tina Bedsted-Faarvang; Peter G W Gettins; Steven T Olson
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

8.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

9.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

10.  The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.

Authors:  Niels Behrendt; Karin List; Peter A Andreasen; Keld Danø
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.